Ruo-Xi Liao
Overview
Explore the profile of Ruo-Xi Liao including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
52
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Duan D, Zhou X, Yan Y, Li Y, Hu Y, Li Q, et al.
Ren Fail
. 2024 Jun;
46(1):2349121.
PMID: 38916144
Background: In recent years, the research on symptom management in peritoneal dialysis (PD) patients has shifted from a single symptom to symptom clusters and network analysis. This study collected and...
2.
Yu Y, Liao R, Li Y, Xiong Y, Su B
Chin Med J (Engl)
. 2021 Jan;
134(3):356-358.
PMID: 33470650
No abstract available.
3.
Yuan L, Liao R, Lin Y, Jiang Y, Wang O, Li M, et al.
J Orthop Translat
. 2019 Sep;
18:109-118.
PMID: 31508314
Background: Primary hypertrophic osteoarthropathy (PHO) is a rare disease involving joint, bone and skin. Two underlying genes responsible for this disease-hydroxyprostaglandin dehydrogenase () and solute carrier organic anion transporter family,...
4.
Liao R, Lyu X, Tang W, Gao K
Clin Transplant
. 2017 Feb;
31(4).
PMID: 28186357
Background: Angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin II receptor type 1 blockers (ARBs) are often prescribed for renal transplant recipients (RTRs), but the outcomes of these medications in RTRs remain...
5.
Yuan L, Chen L, Liao R, Lin Y, Jiang Y, Wang O, et al.
Calcif Tissue Int
. 2015 Jul;
97(4):336-42.
PMID: 26135126
Primary hypertrophic osteoarthropathy (PHO) is a hereditary bone disease characterized by digital clubbing, periostosis, and pachydermia. The HPGD gene encoding 15-prostaglandin dehydrogenase and SLCO2A1 encoding one type of prostaglandin transporter...
6.
Xu L, Jiang Y, Liao R, Zhang H, Mao J, Chi Y, et al.
Antivir Ther
. 2015 Mar;
20(6):603-11.
PMID: 25814481
Background: Adefovir dipivoxil (ADV) nephrotoxicity is well known at a dose of 60 mg day(-1) or 120 mg day(-1). However, renal toxicity at a low-dose of 10 mg ADV for...
7.
Liao R, Yu M, Jiang Y, Xia W
Clin Interv Aging
. 2014 Apr;
9:515-26.
PMID: 24729692
Osteoporosis, a skeletal disorder characterized by a reduction in bone strength, is becoming a major public health problem in the People's Republic of China, with a rapid increase observed among...